Spinal cord stimulation is safe and feasible in patients with advanced heart failure: early clinical experience-Reference-Cited by-同舟云学术

Spinal cord stimulation is safe and feasible in patients with advanced heart failure: early clinical experience

Published:2014-06-24 Issue:7 Volume:16 Page:788-795
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Torre-Amione Guillermo¹²,Alo Kenneth¹,Estep Jerry D.¹,Valderrabano Miguel¹,Khalil Nashwa¹,Farazi Taraneh G.³,Rosenberg Stuart P.³,Ness Lanitia³,Gill John³

Affiliation:

1. Catedra de Cardiologia y Medicina Vascular; Escuela de Medicina; Tecnológico de Monterrey México

2. Houston Methodist DeBakey Heart & Vascular Center; Houston TX USA

3. St. Jude Medical; Sylmar CA USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference21 articles.

1. Spinal cord stimulation: indications and outcomes;Lee;Neurosurg Focus,2006

2. Spinal cord stimulation in the treatment of acute and chronic vasculitis: clinical discussion and synopsis of the literature;Raso;Neuromodulation,2011

3. Spinal cord stimulation in the treatment of chronic critical limb ischemia;Claeys;Acta Neurochir,2007

4. Spinal cord stimulation for intractable angina pectoris;Fanciullo;Anesthes Analg,1999

5. Spinal cord stimulation for ischemic heart disease;DeJongste;Neurol Res,2000

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of spinal cord stimulation as an adjunctive therapy in heart failure: A systematic review;Neurophysiologie Clinique;2024-05

2. Perioperative and anesthetic considerations for the management of neuromodulation systems;Regional Anesthesia & Pain Medicine;2023-04-20

3. Spinal Cord Stimulation Attenuates Neural Remodeling, Inflammation, and Fibrosis After Myocardial Infarction;Neuromodulation: Technology at the Neural Interface;2023-01

4. Neuromodulation in patients with refractory angina pectoris: a review;European Heart Journal Open;2022-12-22

5. Neuromodulation devices for heart failure;European Heart Journal Supplements;2022-08-17